Literature DB >> 19454460

Biliary cancer: ESMO clinical recommendation for diagnosis, treatment and follow-up.

F Eckel1, S Jelic.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19454460     DOI： 10.1093/annonc/mdp125

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.

Authors:  Evan S Glazer; Ping Liu; Eddie K Abdalla; Jean-Nicolas Vauthey; Steven A Curley
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

Review 2.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Chemotherapy for cholangiocarcinoma: An update.

Authors:  Natalia Ramírez-Merino; Santiago Ponce Aix; Hernán Cortés-Funes
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

Review 4.  Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literature.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Elie El Rassy; Fady Ghassan Haddad; Colette Hanna; Fadi El Karak; Dolly Nasr
Journal:  World J Gastrointest Oncol       Date:  2016-10-15

5.  Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.

Authors:  Mohammed Al-Jumayli; Amna Batool; Akshay Middiniti; Anwaar Saeed; Weijing Sun; Raed Al-Rajabi; Joaquina Baranda; Sean Kumer; Timothy Schmitt; Anusha Chidharla; Anup Kasi
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

6.  Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.

Authors:  Eva Braunwarth; Peter Schullian; Moritz Kummann; Simon Reider; Daniel Putzer; Florian Primavesi; Stefan Stättner; Dietmar Öfner; Reto Bale
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.